Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06082635
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2023-10-08
Brief Title:
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer NSCLC
Sponsor:
Organization:
Shenzhen TargetRx Inc